Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Reprogramming Human Cells Without Inserting Genes
A research team comprised of faculty at Worcester Polytechnic Institute"s (WPI) Life Sciences and Bioengineering Center (LSBC) and investigators at CellThera, a private company also located at the LSBC, has discovered a novel way to turn on stem cell genes in human fibroblasts (skin cells) without the risks associated with inserting extra genes or using viruses. This discovery opens a new avenue for reprogramming cells that could eventually lead to treatments for a range of human diseases and traumatic injuries by coaxing a patient"s own cells to repair and regenerate the damaged tissues.

Institute For OneWorld Health And Novartis Launch Innovative Collaboration To Discover And Develop Novel Therapy To Combat Diarrheal Disease
The Institute for OneWorld Health, the US-based non-profit pharmaceutical company that develops drugs for people with neglected infectious diseases in the developing world, today announced that it has launched a collaboration with global pharmaceutical leader Novartis to discover and develop a novel therapy for secretory diarrhea, a deadly disease that kills more than 1.6 million children in the developing world each year.
News of the day
National Association Of Pediatric Nurse Practitioners Supports The Preserving Patient Access To Primary Care Act
The National Association of Pediatric Nurse Practitioners (NAPNAP) praises Representative Allyson Schwartz and nearly 100 cosponsors of The Preserving Patient Access to Primary Care Act for their leadership in health care reform. This legislation, which will increase the number of primary care providers and improve patient access to primary care services, is a critical step if we truly are to reform our health care delivery system. Our nation needs leaders like Representative Schwartz to affect real and lasting change in our health care system.
Medical Devices

Availability Of IVF Treatment In UK Still Poor Compared With Rest Of Europe

Commenting on the news announced today by ESHRE"s European IVF monitoring consortium on the improvements in the quality, safety and efficacy of ART, Clare Lewis-Jones MBE, Chief Executive of Infertility Network UK said "We are angry that although the UK pioneered infertility treatment, we are still among the lowest providers in Europe of NHS treatment, and these figures show that availability in the UK is less than one third of that in Denmark. Recent measures announced by the Government to encourage implementation of the NICE Guideline have led to an improvement in the provision in some areas but more needs to be done by Primary Care Trusts in England to ensure that patients have equal and timely access to the full range of treatment recommended by NICE, and to tackle the ongoing variations in provision that exist across the country. Ms Lewis-Jones went on to say "Although there has been an improvement recently in the provision of treatment by some PCTs, there still remains considerable variation in the criteria used to determine whether or not couples can access treatment. We welcome the recent measures announced by the Government to encourage implementation of the Guideline but particularly with the move towards single embryo transfer (SET) more needs to be done by the PCTs to fund three full cycles as recommended in the NICE Guideline and to standardise the access criteria they use to determine who can access NHS treatment and allow couples to have the treatment they need to help them have their family. To be so far behind other countries in Europe in the provision of fertility treatment is totally intolerable" Infertility Network UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009